chr21-41766883-C-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_020639.3(RIPK4):​c.159G>A​(p.Ser53=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.137 in 1,609,716 control chromosomes in the GnomAD database, including 16,468 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S53S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.14 ( 1554 hom., cov: 33)
Exomes 𝑓: 0.14 ( 14914 hom. )

Consequence

RIPK4
NM_020639.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0540
Variant links:
Genes affected
RIPK4 (HGNC:496): (receptor interacting serine/threonine kinase 4) The protein encoded by this gene is a serine/threonine protein kinase that interacts with protein kinase C-delta. The encoded protein can also activate NFkappaB and is required for keratinocyte differentiation. This kinase undergoes autophosphorylation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.25).
BP6
Variant 21-41766883-C-T is Benign according to our data. Variant chr21-41766883-C-T is described in ClinVar as [Benign]. Clinvar id is 340036.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-41766883-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.18 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RIPK4NM_020639.3 linkuse as main transcriptc.159G>A p.Ser53= synonymous_variant 1/8 ENST00000332512.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RIPK4ENST00000332512.8 linkuse as main transcriptc.159G>A p.Ser53= synonymous_variant 1/81 NM_020639.3 P1P57078-2
RIPK4ENST00000352483.3 linkuse as main transcriptc.159G>A p.Ser53= synonymous_variant 1/95 P57078-1

Frequencies

GnomAD3 genomes
AF:
0.137
AC:
20854
AN:
151928
Hom.:
1551
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.183
Gnomad AMI
AF:
0.0681
Gnomad AMR
AF:
0.0973
Gnomad ASJ
AF:
0.0611
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0502
Gnomad FIN
AF:
0.112
Gnomad MID
AF:
0.0510
Gnomad NFE
AF:
0.145
Gnomad OTH
AF:
0.116
GnomAD3 exomes
AF:
0.106
AC:
25347
AN:
239656
Hom.:
1710
AF XY:
0.105
AC XY:
13792
AN XY:
131546
show subpopulations
Gnomad AFR exome
AF:
0.188
Gnomad AMR exome
AF:
0.0579
Gnomad ASJ exome
AF:
0.0645
Gnomad EAS exome
AF:
0.000452
Gnomad SAS exome
AF:
0.0601
Gnomad FIN exome
AF:
0.122
Gnomad NFE exome
AF:
0.141
Gnomad OTH exome
AF:
0.108
GnomAD4 exome
AF:
0.137
AC:
199172
AN:
1457676
Hom.:
14914
Cov.:
33
AF XY:
0.133
AC XY:
96794
AN XY:
725122
show subpopulations
Gnomad4 AFR exome
AF:
0.186
Gnomad4 AMR exome
AF:
0.0632
Gnomad4 ASJ exome
AF:
0.0650
Gnomad4 EAS exome
AF:
0.000203
Gnomad4 SAS exome
AF:
0.0609
Gnomad4 FIN exome
AF:
0.123
Gnomad4 NFE exome
AF:
0.152
Gnomad4 OTH exome
AF:
0.125
GnomAD4 genome
AF:
0.137
AC:
20866
AN:
152040
Hom.:
1554
Cov.:
33
AF XY:
0.132
AC XY:
9792
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.183
Gnomad4 AMR
AF:
0.0971
Gnomad4 ASJ
AF:
0.0611
Gnomad4 EAS
AF:
0.000387
Gnomad4 SAS
AF:
0.0498
Gnomad4 FIN
AF:
0.112
Gnomad4 NFE
AF:
0.145
Gnomad4 OTH
AF:
0.115
Alfa
AF:
0.131
Hom.:
2887
Bravo
AF:
0.138
Asia WGS
AF:
0.0360
AC:
126
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxNov 02, 2019- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Bartsocas-Papas syndrome 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.25
CADD
Benign
14
DANN
Benign
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6586238; hg19: chr21-43187043; API